UDG Healthcare (LON:UDG) insider Chris Corbin sold 730,000 shares of the business’s stock in a transaction that occurred on Tuesday, March 13th. The shares were sold at an average price of GBX 870 ($12.21), for a total transaction of £6,351,000 ($8,914,935.43).
Shares of UDG traded up GBX 8.50 ($0.12) during mid-day trading on Friday, hitting GBX 882.50 ($12.39). 727,762 shares of the company’s stock were exchanged, compared to its average volume of 981,360. UDG Healthcare has a twelve month low of GBX 690 ($9.69) and a twelve month high of GBX 963 ($13.52).
UDG has been the topic of a number of recent analyst reports. Peel Hunt restated an “add” rating and set a GBX 880 ($12.35) price target on shares of UDG Healthcare in a report on Tuesday, December 19th. Numis Securities restated a “reduce” rating and set a GBX 765 ($10.74) price target on shares of UDG Healthcare in a report on Tuesday, January 30th. Liberum Capital upgraded shares of UDG Healthcare to a “buy” rating and set a GBX 884 ($12.41) price objective on the stock in a research note on Wednesday, February 7th. Jefferies Group reiterated a “hold” rating and issued a GBX 820 ($11.51) price objective on shares of UDG Healthcare in a research note on Wednesday, January 17th. Finally, Libertas Partners upgraded shares of UDG Healthcare to a “buy” rating and set a GBX 884 ($12.41) price objective on the stock in a research note on Wednesday, February 7th. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and two have issued a buy rating to the company’s stock. UDG Healthcare currently has an average rating of “Hold” and a consensus price target of GBX 832.63 ($11.69).
TRADEMARK VIOLATION NOTICE: “UDG Healthcare (UDG) Insider Chris Corbin Sells 730,000 Shares” was first posted by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this story on another site, it was copied illegally and reposted in violation of U.S. & international trademark and copyright law. The original version of this story can be viewed at https://www.dispatchtribunal.com/2018/04/07/udg-healthcare-plc-udg-insider-chris-corbin-sells-730000-shares.html.
UDG Healthcare Company Profile
UDG Healthcare PLC, formerly United Drug PLC, provides advisory, commercial, clinical, communications and packaging services to the healthcare industry with operations in approximately 24 countries and delivering services in over 50 countries. The Company operates across three divisions: Ashfield, which provides commercialization services for the pharmaceutical and healthcare industry and operates across two areas of activity: advisory & communications services and commercial & clinical services and provides healthcare communications, patient support, audit, advisory, medical information and event management services; Sharp, which provides contract commercial packaging and clinical trial packaging services for the pharmaceutical and biotechnology industries and operates facilities in the United States and Europe; and Aquilant, which provides outsourced sales, marketing, distribution and engineering services to the medical and scientific sectors in the UK, Ireland and the Netherlands.
Receive News & Ratings for UDG Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UDG Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.